TIL Therapy in Lung Cancer: Current Progress and Perspectives.

Area of Science:

• Oncology
• Immunotherapy

Background:

• Lung cancer is a leading cause of cancer mortality globally.
• Current immunotherapies like immune checkpoint blockade have limitations, with many patients not responding due to insufficient T cell infiltration.

Purpose of the Study:

• To review tumor-infiltrating lymphocyte (TIL) therapy as a potential treatment for lung cancer.
• To discuss the suitability, development, and optimization strategies for TIL therapy in lung cancer.

Main Methods:

• Review of historical and clinical developments in TIL therapy.
• Summary of methods for identifying tumor-recognizing TILs and optimizing TIL composition.

Main Results:

• TIL therapy, a form of adoptive cell therapy (ACT), involves reinfusing expanded autologous T cells from resected tumors.
• This approach holds significant therapeutic potential for lung cancer patients.

Conclusions:

• TIL therapy is a promising therapeutic modality for lung cancer.
• Further research into identifying and optimizing TILs can enhance treatment efficacy.